IoN Trial

Collection of samples and data across the following diseases: Malignant tumour of thyroid gland (disorder). IoN is a multicentre phase II/III asking is ablative radioiodine necessary for low risk differentiated thyroid cancer patients. 560 patients will be recruited and randomised 1:1 to receive radioiodine ablation or no ablation. Samples collected during trial: Stimulated Tg blood samples for patients taken at the treatment visit, 2 months post treatment, 6-9 months post treatment and every 6 months thereafter for 5 years.

Webpage:
https://www.healthdatagateway.org/dataset/17cd75a2-e2b5-440c-89b1-22c9f3b03a03

Licence:
Name: HDR UK Innovation Gateway Access
URL: https://www.hdruk.ac.uk/infrastructure/gateway/terms-and-conditions/

Tags:

trial malignant tumour of thyroid gland (disorder) ion

More to explore:

1/20

Previous Next   



Need help integrating and/or managing biomedical data?